Tactile Systems Technology, Inc.

TCMD

NASDAQHealthcareMedical - Devices

在 GoAI 中打開

前收盤價

US$23.82

+US$0.39 · +1.66%

8月21日下午4:00 ET

盤中時間採用ET。市場資料可能有所延遲。

GoAI 研究快照

簡明呈現最新可用的模型資訊。

2026年7月10日

70/ 100

GoAI評分

Buy

Favorable setup — positive multi-factor alignment

估值

Deep Value

動能

Gaining

情緒

Bullish

風險韌性

Elevated Risk

完整 GoAI 研究

繼續查看更深入的依據、催化因素和風險。

看完整研究

人工智慧產生的上下文僅供參考，並非投資建議。

公司概況

公司網站

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.

產業: Medical - Devices
部門: Healthcare
總部: US
執行長: Sheri Louise Dodd
上市以來: 2016年7月28日
僱員: 1,086

市場位置

日內區間

目前US$23.82，

US$23.57US$23.94

52週區間

目前US$23.82，

US$12.81US$37.77

開盤價: US$23.57
前收盤價: US$23.43
成交量: 35.65萬; 1.15× 平均值
平均成交量: 30.94萬; 日均成交量
市值: 5.37億 USD
貝塔: 0.82; 市場參考 1
50天平均值: US$27.7508; 低於平均水平-14.16%
200天平均值: US$26.9762; 低於平均水平-11.70%

財務數據

財務快照

估值與收益率

企業價值: 5.96億 USD
本益比（TTM）: 21.85×
股價淨值比（TTM）: 2.41×
股價營收比（TTM）: 1.53×
EV/EBITDA: 15.27×
盈餘收益率: 2.88%
自由現金流收益率: 6.10%
股息率: 0.00%

獲利能力和效率

毛利率: 74.23%
營業利益率: 10.00%
淨利潤率: 7.10%
股東權益報酬率: 8.72%
資產報酬率: 6.97%
投入資本報酬率: 7.55%

財務健康

負債權益比: 0.06×
流動比率: 4.03×
奧特曼 Z 分數: 8.29
皮奧特羅斯基 F 分數: 8 共 9 個

分析師評級

第三方分析師預期可能變動，並非 GoAI 建議。

分析師目標價

平均目標

US$40.00

上漲空間 67.93%

過去 12 個月12個月預測最高：US$40.00平均的：US$40.00最低：US$40.00

評級分佈

11項評級

強力買進00%

買進873%

持有19%

賣出218%

強力賣出00%

近期分析師行動

4 機構

Lake StreetmaintainBuy2025年11月4日

TCMD 訊息

seekingalpha.com2026年8月10日

Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript

閱讀原始碼

marketbeat.com2026年8月10日

Tactile Systems Technology Q2 Earnings Call Highlights

Tactile Systems Technology NASDAQ: TCMD, doing business as Tactile Medical, reported second-quarter revenue growth and higher profitability, led by its lymphedema business, while updating its full-year outlook to reflect…

閱讀原始碼

zacks.com2026年8月10日

Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates

Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.14 per share a year ago.

閱讀原始碼

globenewswire.com2026年7月21日

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today…

閱讀原始碼

globenewswire.com2026年7月13日

Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression

閱讀原始碼

zacks.com2026年6月29日

Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?

Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

閱讀原始碼